Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer

6376.50
0.25%
HDFC Securities
Post the import alert (IA) on its crucial Unit II plant, Divis Labs (DIVI) reported mixed 4QFY17 numbers. The top-line declined 3% YoY, and the EBITDA margin came in at ~34% (vs ~36% in 4QFY16).
Divi's Laboratories Ltd. average weekly volume is high.
More from Divi's Laboratories Ltd.
Recommended